These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38476610)

  • 1. Prognostic biomarker CPEB3 and its associations with immune infiltration in clear cell renal cell carcinoma.
    Hong H; Shi X; Ou W; Ou P
    Biomed Rep; 2024 Apr; 20(4):63. PubMed ID: 38476610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma.
    Yang H; Zhang H; Zhang L; Tusuphan P; Zheng J
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
    Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.
    Stenzel PJ; Schindeldecker M; Tagscherer KE; Foersch S; Herpel E; Hohenfellner M; Hatiboglu G; Alt J; Thomas C; Haferkamp A; Roth W; Macher-Goeppinger S
    Transl Oncol; 2020 Feb; 13(2):336-345. PubMed ID: 31881506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.
    Monjaras-Avila CU; Lorenzo-Leal AC; Luque-Badillo AC; D'Costa N; Chavez-Muñoz C; Bach H
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175653
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
    Yuan X; He Y; Luo C; Wang W
    Invest New Drugs; 2022 Apr; 40(2):232-244. PubMed ID: 34633577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma.
    Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W
    Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
    Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
    Front Immunol; 2022; 13():890150. PubMed ID: 35686121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma.
    Cao Q; Liu D; Chen Z; Wang M; Wu M; Zeng G
    Cell Signal; 2023 Feb; 102():110556. PubMed ID: 36503163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.
    Jiang W; Zeng H; Liu Z; Jin K; Hu B; Chang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
    Urol Oncol; 2022 Apr; 40(4):166.e15-166.e25. PubMed ID: 34998671
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
    Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the role of CXCL family members in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Zhang P; Xu Y; Yang T; Xia Q
    Curr Cancer Drug Targets; 2023 Aug; ():. PubMed ID: 37641996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
    Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
    Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.
    Zhang H; Liu Y; Wang B; Wang C
    BMC Genom Data; 2022 Jul; 23(1):58. PubMed ID: 35883015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Expression of CPEB3 Predicts a Poor Prognosis in Patients with Melanoma: A Study Based on TCGA Data.
    Zhang X; Liang Y
    Biomed Res Int; 2021; 2021():8197936. PubMed ID: 33506034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
    Fu Q; Xu L; Wang Y; Jiang Q; Liu Z; Zhang J; Zhou Q; Zeng H; Tong S; Wang T; Qi Y; Hu B; Fu H; Xie H; Zhou L; Chang Y; Zhu Y; Dai B; Zhang W; Xu J
    Eur Urol; 2019 May; 75(5):752-763. PubMed ID: 30293904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
    Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
    Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.